论文部分内容阅读
用经典的临床前和临床试验方法 ,阐述一种治疗急性胰腺炎的新药来昔帕泛 (一种有效的血小板活化因子拮抗剂 )的药理及临床疗效。在急性胰腺炎的早期治疗过程中 ,来昔帕泛对胰腺炎患者有减少炎症过程及器官衰竭发生率的良好作用。多用静滴 10 0mg/d ,共 7d ,它可使重症患者器官衰竭较快恢复 ,阻止轻症患者产生新的器官衰竭。来昔帕泛是治疗急性胰腺炎第一个显示有明显效果的特殊药物
Using classical preclinical and clinical trial methods, elucidate the pharmacology and clinical efficacy of a new drug, proiprost, a potent platelet-activating factor antagonist, for the treatment of acute pancreatitis. In the early treatment of acute pancreatitis, the treatment of pancreatitis in patients with sepsis pancreas reduce the inflammatory process and the incidence of organ failure good effect. Multi-use intravenous infusion of 10 0mg / d, a total of 7d, it can make the recovery of organ failure in critically ill patients to prevent new patients with mild organ failure. Panax Panax is the first drug to treat acute pancreatitis with significant effects